Bisphosphonates and osteonecrosis of jaws
Bisphosphonates are used to treat osteoporosis. Paget disease of bone and other metabolic bone diseases, multiple myeloma, and skeletal events associated with metastatic neoplasms- In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates were publish...
Saved in:
Main Authors: | Geetha Vijay (Author), Vijay Raghavan (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bisphosphonate-associated osteonecrosis of the jaws
by: Rajiv S Desai, et al.
Published: (2012) -
Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012) -
Osteonecrosis of the Jaws in Treatment with Bisphosphonates
by: M. Machálka, et al.
Published: (2006) -
Bisphosphonate-related osteonecrosis of the jaw: An insight
by: Shalini Kapoor, et al.
Published: (2013) -
Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014)